Monarch Partners Asset Management LLC Kala Pharmaceuticals, Inc. Transaction History

Monarch Partners Asset Management LLC

  • $328 Million
  • Q4 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 04, 2021
SELL
$6.28 - $8.79 $363,806 - $509,213
-57,931 Closed
0 $0
Q3 2020

Nov 05, 2020
BUY
$7.5 - $11.11 $213,720 - $316,590
28,496 Added 96.81%
57,931 $434,000
Q2 2020

Jul 31, 2020
BUY
$8.33 - $13.79 $101,084 - $167,341
12,135 Added 70.14%
29,435 $309,000
Q1 2020

May 04, 2020
BUY
$3.83 - $8.79 $66,259 - $152,066
17,300 New
17,300 $152,000

Others Institutions Holding KALA

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0
View Full List

About Kala Pharmaceuticals, Inc.

KALA Quotes by TradingView
  • Ticker KALA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,464,160
  • Market Cap $9.96M
  • Description
  • Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...
More about KALA
Track This Portfolio

Track Monarch Partners Asset Management LLC Portfolio

Follow Monarch Partners Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monarch Partners Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monarch Partners Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email